| Dr Anna Gramling, MD | |
|
1100 Southfield Dr, Suite 1330, Plainfield, IN 46168-4498 | |
| (317) 837-5510 | |
| (317) 837-5520 |
| Full Name | Dr Anna Gramling |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 23 Years |
| Location | 1100 Southfield Dr, Plainfield, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508033408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 01072820A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendricks Regional Health | Danville, IN | Hospital |
| Franciscan Health Mooresville | Mooresville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendricks County Hospital | 4880505528 | 274 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge. Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for amlodipine and valsartan and was granted 180 days of marketing exclusivity.
A groundbreaking study of nearly 4,000 trauma patients evacuated from the frontlines in Afghanistan over a six-year period offers insight that can inform decisions on team composition, staff training and skill mix on the battlefield and beyond.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.
› Verified 1 days ago
| Entity Name | Hendricks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063411551 PECOS PAC ID: 4880505528 Enrollment ID: O20040811000309 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge. Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for amlodipine and valsartan and was granted 180 days of marketing exclusivity.
A groundbreaking study of nearly 4,000 trauma patients evacuated from the frontlines in Afghanistan over a six-year period offers insight that can inform decisions on team composition, staff training and skill mix on the battlefield and beyond.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anna Gramling, MD 1100 Southfield Dr, Suite 1370, Plainfield, IN 46168-4498 Ph: (317) 837-5571 | Dr Anna Gramling, MD 1100 Southfield Dr, Suite 1330, Plainfield, IN 46168-4498 Ph: (317) 837-5510 |
News Archive
Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge. Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for amlodipine and valsartan and was granted 180 days of marketing exclusivity.
A groundbreaking study of nearly 4,000 trauma patients evacuated from the frontlines in Afghanistan over a six-year period offers insight that can inform decisions on team composition, staff training and skill mix on the battlefield and beyond.
Plexxikon Inc. today announced promising preclinical data from in vivo cancer studies with PLX3397 demonstrating significant reduction in tumor burden, metastatic spread, bone erosion and cancer bone pain. PLX3397 is an oral, selective kinase inhibitor that down-modulates macrophages, microglia, osteoclasts and mast cells, all cell types targeted by this drug candidate. These cell types play a key role in cancer and metastasis.
MedAssets today announced that Advocate Health Care, a 12-hospital, 3,300-bed health system based in Downers Grove, Ill., renewed its performance improvement relationship with MedAssets to drive sustainable cost reductions, improve operational efficiencies and ultimately, the standard of care. The renewal builds upon Advocate's recent success in total cost management initiatives including MedAssets Strategic Sourcing, Capital and Construction, Procure-to-Pay solutions and Cost Analytics.
› Verified 1 days ago
Kimberly S Berebitsky, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1100 Southfield Dr Ste 1240, Plainfield, IN 46168 Phone: 317-838-9911 Fax: 317-837-6080 | |
Dr. Bethany Lanae Molt, D.O. Rheumatology Medicare: Medicare Enrolled Practice Location: 727 Moon Rd, Plainfield, IN 46168 Phone: 317-839-2513 | |
Marcia A Johnson, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1100 Southfield Dr Ste 1330, Plainfield, IN 46168 Phone: 317-837-5510 Fax: 317-837-5520 | |
Vada Lafranze Durr-stein, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 2680 E Main St Ste 317, Plainfield, IN 46168 Phone: 317-546-0366 | |
Laura J Nelson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1100 Southfield Dr Ste 1220, Plainfield, IN 46168 Phone: 317-838-3443 Fax: 317-838-3444 | |
Hannah Marie Kenninger Krebsbach, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1100 Southfield Dr Ste 1300, Plainfield, IN 46168 Phone: 317-837-5510 |